Literature DB >> 8032583

Characterization of ETB receptors mediating contractions induced by endothelin-1 or IRL 1620 in guinea-pig isolated airways: effects of BQ-123, FR139317 or PD 145065.

B Battistini1, T D Warner, A Fournier, J R Vane.   

Abstract

1. We have characterized the receptors mediating contractions to endothelin-1 (ET-1) or IRL 1620, an ETB receptor selective agonist, in isolated strips of tissue prepared from different parts of the guinea-pig airways. We used as antagonists BQ-123 and FR139317 (ETA receptor-selective) and PD 145065 (ETA/ETB receptor non-selective). 2. ET-1 and IRL 1620 (10(-10) M to 10(-6) M) caused similar concentration-dependent contractions of strips of guinea-pig trachea and upper bronchus. In the guinea-pig trachea without epithelium or lung parenchyma, IRL 1620 was less potent than ET-1. 3. In the trachea, contraction to ET-1 (< 10(-8) M) was preceded by a transient relaxation which was inhibited by BQ-123 (10(-5) M) or FR 139317 (10(-5) M) or by the removal of the epithelium. The concentration-response curve to ET-1 in the trachea was shifted to the right by PD 145065 (10(-5) M to 10(-4) M). PD 145065 (10(-4) M) also inhibited the response to ET-1 (3 x 10(-7) M) by 55%. Contractions induced by IRL 1620 were not affected by BQ-123 (10(-6) M) or FR139317 (10(-6) M) but were significantly attenuated by 10(-5) M of either antagonist. PD 145065 at 10(-6) M strongly attenuated and at 10(-5) M abolished contractions induced by IRL 1620. 4. In the trachea, removal of the epithelium potentiated the effects of both agonists. BQ-123 (10-5 M)had no effect on contractions of the trachea without epithelium induced by ET-1, but FR139317 (10-5 M)caused a significant inhibition. PD 145065 (10-5 M to 10-4 M) caused a shift to the right of the ET-1 concentration-response curve without affecting the contractile effect at 3 x 10-7 M. All three antagonists inhibited contractions induced by IRL 1620.5. In the upper bronchus, BQ-123 (10-5 M) did not affect contractions induced by ET-1, whileFR139317 (10-5 M) attenuated (20-26%) only contractions induced by 1-3 x 10-7 M ET-1. PD 145065(10-5 M to 10-4 M) caused a shift to the right of the ET-1 concentration-response curve. The contractions induced by IRL 1620 were inhibited by BQ-123 or FR139317 (10-5M to 10-4 M). PD 145065(10-6 M) strongly inhibited contractions induced by IRL 1620 and PD 145065 (10-5 M) totally abolished them.6. The contractile action of ET-1 in the lung parenchyma was significantly and similarly attenuated by BQ-123 (10-5 M) or indomethacin (10-5 M), while FRI39317 (10-5 M) was less effective. PD 145065(10-6 to 10-5 M) inhibited contractions to ET-1. IRL 1620, which is less potent than ET-1 in this preparation, was antagonized by PD 145065 (10-5 to 10-6 M) but unaffected by BQ-123 (10-6 M to10-5M) or FR139317 (10-6 M).7. Thus, ETB receptors mediate contractions to ET-1 in all four guinea-pig airway preparations. In addition, contractions to ET-1 in the trachea and lung parenchyma are mediated in part by ETA receptors. In the latter tissue, these ETA receptors mediate contraction through the release of cyclooxygenase metabolites. Similarly, ETA receptors located on the epithelial cells also mediate the release of prostanoids in the trachea with epithelium but they are responsible for transient relaxations. Interestingly,contractions induced by IRL 1620 were more susceptible to inhibition by the different antagonists,most probably because it binds to the endothelin receptors in a reversible manner. High concentrations(10-5 M) of ETA-selective antagonists also inhibit responses to IRL 1620, most probably by an effect at ETB receptors in both the trachea and the upper bronchus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8032583      PMCID: PMC1910170          DOI: 10.1111/j.1476-5381.1994.tb14844.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  41 in total

1.  In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor.

Authors:  M Ihara; K Ishikawa; T Fukuroda; T Saeki; K Funabashi; T Fukami; H Suda; M Yano
Journal:  J Cardiovasc Pharmacol       Date:  1992       Impact factor: 3.105

2.  Subtype selectivity of a novel endothelin antagonist, FR139317, for the two endothelin receptors in transfected Chinese hamster ovary cells.

Authors:  I Aramori; H Nirei; M Shoubo; K Sogabe; K Nakamura; H Kojo; Y Notsu; T Ono; S Nakanishi
Journal:  Mol Pharmacol       Date:  1993-02       Impact factor: 4.436

3.  Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist.

Authors:  M Clozel; V Breu; K Burri; J M Cassal; W Fischli; G A Gray; G Hirth; B M Löffler; M Müller; W Neidhart
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

4.  Endothelin-1-induced increases in microvascular permeability in isolated, perfused rat lungs requires leukocytes and plasma.

Authors:  E Helset; J Kjaeve; A Hauge
Journal:  Circ Shock       Date:  1993-01

5.  Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anaesthetized rat.

Authors:  J P Cristol; T D Warner; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-03       Impact factor: 8.739

6.  Endothelin-1 (ET-1)-induced contraction in rat isolated trachea: involvement of ETA and ETB receptors and multiple signal transduction systems.

Authors:  P J Henry
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist.

Authors:  K Sogabe; H Nirei; M Shoubo; A Nomoto; S Ao; Y Notsu; T Ono
Journal:  J Pharmacol Exp Ther       Date:  1993-03       Impact factor: 4.030

8.  Role of endothelin ETB receptors in bronchoconstrictor and vasoconstrictor responses in guinea-pigs.

Authors:  K Noguchi; Y Noguchi; H Hirose; M Nishikibe; M Ihara; K Ishikawa; M Yano
Journal:  Eur J Pharmacol       Date:  1993-03-16       Impact factor: 4.432

9.  A novel ETA-receptor antagonist, FR 139317, inhibits endothelin-induced contractions of guinea-pig pulmonary arteries, but not trachea.

Authors:  L O Cardell; R Uddman; L Edvinsson
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

10.  Use of the endothelin antagonists BQ-123 and PD 142893 to reveal three endothelin receptors mediating smooth muscle contraction and the release of EDRF.

Authors:  T D Warner; G H Allcock; R Corder; J R Vane
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

View more
  15 in total

1.  Endothelin-1 increases cholinergic nerve-mediated contraction of human bronchi via tachykinin synthesis induction.

Authors:  B D'Agostino; C Advenier; M Falciani; L Gallelli; G Marrocco; E Piegari; A Filippelli; F Rossi
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

2.  Necessity of dual blockade of endothelin ETA and ETB receptor subtypes for antagonism of endothelin-1-induced contraction in human bronchi.

Authors:  T Fukuroda; S Ozaki; M Ihara; K Ishikawa; M Yano; T Miyauchi; S Ishikawa; M Onizuka; K Goto; M Nishikibe
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Endothelins-induce cyclicAMP formation in the guinea-pig trachea through an ETA receptor- and cyclooxygenase-dependent mechanism.

Authors:  A M el-Mowafy; G A Abou-Mohamed
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

Review 4.  Endothelin and hepatic wound healing.

Authors:  Al-karim Khimji; Don C Rockey
Journal:  Pharmacol Res       Date:  2011-03-21       Impact factor: 7.658

5.  Comparison of endothelin B (ETB) receptors in rabbit isolated pulmonary artery and bronchus.

Authors:  D W Hay; M A Luttmann; G Beck; E H Ohlstein
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

6.  Influence of regional differences in ETA and ETB receptor subtype proportions on endothelin-1-induced contractions in porcine isolated trachea and bronchus.

Authors:  R G Goldie; A C D'Aprile; R Cvetkovski; P J Rigby; P J Henry
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

7.  Role of the neutral endopeptidase 24.11 in the conversion of big endothelins in guinea-pig lung parenchyma.

Authors:  N Lebel; P D'Orléans-Juste; A Fournier; P Sirois
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Actions of endothelins and sarafotoxin 6c in the rat isolated perfused lung.

Authors:  H Lal; B Woodward; K I Williams
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

9.  Contractile activity of endothelin precursors in the isolated gallbladder of the guinea-pig: presence of an endothelin-converting enzyme.

Authors:  B Battistini; M Woods; L J O'Donnell; T D Warner; R Corder; A Fournier; M J Farthing; J R Vane
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

10.  Characterization of endothelin (ET) receptors in the isolated gall bladder of the guinea-pig: evidence for an additional ET receptor subtype.

Authors:  B Battistini; L J O'Donnell; T D Warner; A Fournier; M J Farthing; J R Vane
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.